Bulletin of the Korean Chemical Society

Korean Chemical Society (대한화학회)
권호 표지
DOI QR코드

DOI QR Code

Solution Conformations of the Substrates and Inhibitor of Hepatitis C Virus NS3 Protease

  • Published : 1999.03.20
Download PDF
⟨ Previous Next ⟩

Abstract

Hepatitis C virus (HCV) has been known to be an enveloped virus with a positive strand RNA genome and the major agent of the vast majority of transfusion associated cases of hepatitis. For viral replication, HCV structural proteins are first processed by host cell signal peptidases and NS2/NS3 site of the nonstructural protein is cleaved by a zinc-dependent protease NS2 with N-terminal NS3. The four remaining junctions are cleaved by a separate NS3 protease. The solution conformations of NS4B/5A, NS5A/5B substrates and NS5A/5B inhibitor have been determined by two-dimensional nuclear magnetic resonance (NMR) spectroscopy. NMR data suggested that the both NS5A/5B substrate and inhibitor appeared to have a folded tum-like conformation not only between P1 and P6 position but also C-terminal region, whereas the NS4B/5A substrate exhibited mostly extended conformation. In addition, we have found that the conformation of the NS5A/5B inhibitor slightly differs from that of NS5A/5B substrate peptide, suggesting different binding mode for NS3 protease. These findings will be of importance for designing efficient inhibitor to suppress HCV processing.

Keywords

References

  1. FEMS Microbiol. Rev. v.14 Purcell, R. H.
  2. Proc. Natl. Acad. Sci. USA v.24 Kato, N.;Hijikata, M.;Ootsuyama, Y.;Nakagawa, m.;Ohkoshi, S.;Sugimura, T.;Shimotohno, K.
  3. Proc. Natl. Acad. Sci. USA v.88 Choo, Q. L.;Richman, K. H.;Han, J. H.;Berger, K.;Lee, C.;Dong, C.;Gallegos, C.;Colt, D.;Medina-Selby, A.;Barr, P. J.
  4. J. Virol. v.65 Takamizawa, A.;Mori, C.;Fuke, I.;Manabe, S.;Murakami, S.;Fujita, J.;Onishi, E.;Andon, T.;Yoshida, I.;Okayama, H.
  5. J. Virol. v.67 Grakoui, A.;McCourt, D. W.;Wychowski, C.;Feinstone, S. M.;Rice, C. M.
  6. J. Virol. v.67 Hijikata, M.;Mizushima, H.;Akagi, T.;Mori, S.;Kakiuchi, N.;Kato, N.;Tanaka, T.;Kimura, K.;Shimotohno, K.
  7. J. Virol. v.70 Simizu, Y.;Yamaji, K.;Massiho, Y.;Yokota, T.;Inoue, H.;Sudo, K.;Satoh, S.;Shimotohno, K.
  8. Cell v.87 Kim, J. L.;Morgenstern, K. A.;Lin, C.;Fox, T.;Dwyer, M. D.;Landro, J. A.;Chambers, S. P.;Markland, W.;Lepre, C. A.;OMalley, E. T.;Harbeson, S. L.;Rice, C. M.;Murcko, M. A.;Carson, P. R.;Thomson, J. A.
  9. Cell v.87 Love, R. A.;Parge, H. E.;Wickersham, J. A.;Habuka, N.;Moomaw, E. W.;Adachi, T.;Hostomska, Z.
  10. J. Virol. v.67 Grakoui, A.;McCourt, D. W.;Wychowski, C.;Feinstone, S. M.;Rice, C. M.
  11. Analyt. Chem. v.42 Van Geet, A. L.
  12. J. Chem. Phys. v.71 Jeener, J. Meier, B. H.;Bachmann, P.;Ernst, R. R.
  13. J. Am. Chem. Soc. v.107 Davis, D. G.;Bax, A.
  14. J. Am. Chem. Soc. v.104 Piantini, U.;Sorensen, O. W.;Ernst, R. R.
  15. Biochem. Biophys. Res. Commun. v.113 Marion, D.;Wuthrich, K.
  16. J. Magn. Reson. v.66 Otting, G.;Widmer, H.;Wagner, G.;Wuthrich, K.
  17. Biochemistry v.28 Driscoll, P. C.;Gronenborn, A. M.;Beress, L.;Clore, G. M.
  18. FEBS Lett v.229 Nilges, M.;Clore, G. M.;Gronenborn, A. M.
  19. Eur. J. Biochem. v.218 Lee, W.;Moore, C. H.;Watt, D. D.;Krishna, N. R.
  20. NMR of Proteins and Nucleic Acids Wuthrich, K.
  21. J. Appl. Cryst. v.24 Kraulis, P. J.
  22. Methods in Enzymology v.277 Merritt, E. A.;Bacon, D. J .